Search Within

Alexander Meyer Lesokhin

Formats
  1. Meeting Abstract (243)
  2. Journal Article (97)
  3. Research Letter (10)
  4. Review (7)
  5. Correspondence (3)
  6. Book Section (2)
  7. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (364)
  2. Department of Medicine (364)
  3. Hematologic Malignancies Research (364)
  4. Hematologic Malignancies, Division of (364)
  5. Myeloma (364)
  6. Survivorship Research (212)

More Groups

People
  1. Hani Hassoun (193)
  2. Heather Landau (177)
  3. Sergio Giralt (174)
  4. David Chung (168)
  5. Neha Korde (162)
  6. Sham Mailankody (159)

More People

Years
  1. 2025 (3)
  2. 2024 (44)
  3. 2023 (77)
  4. 2022 (51)
  5. 2021 (31)
  6. 2020 (18)

More Years

Publications
  1. Blood (132)
  2. Clinical Lymphoma, Myeloma and Leukemia (57)
  3. Journal of Clinical Oncology (40)
  4. Biology of Blood and Marrow Transplantation (13)
  5. Leukemia and Lymphoma (12)
  6. Blood Advances (10)

More Publications

Publishers
  1. American Society of Hematology (142)
  2. Elsevier Inc. (78)
  3. American Society of Clinical Oncology (40)
  4. Nature Publishing Group (23)
  5. American Association for Cancer Research (14)
  6. Taylor & Francis Group (12)

More Publishers

Results (364)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcome of patients with multiple myeloma treated with autologous stem cell transplantation in the era of novel therapies
    Meeting Abstract

    Hassoun, H.; Landau, H.; Surti, C.; Adel, N. G.; Jia, X. Y.; Riedel, E. R.; Manisha, B.; Comenzo, R.; Lesokhin, A.; Chung, D. J.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Self-antigen-specifc CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
    Journal Article

    Rizzuto, G. A.; Merghoub, T.; Hirschhorn-Cymerman, D.; Liu, C.; Lesokhin, A. M.; Sahawneh, D.; Zhong, H.; Panageas, K. S.; Perales, M. A.; Altan-Bonnet, G.; more...
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
    Journal Article

    Hirschhorn-Cymerman, D.; Rizzuto, G. A.; Merghoub, T.; Cohen, A. D.; Avogadri, F.; Lesokhin, A. M.; Weinberg, A. D.; Wolchok, J. D.; Houghton, A. N.
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save